Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 82.75
-1.30 (-1.55%)
Sep 3, 2026, 3:19 PM AST
Dallah Healthcare Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Dallah Healthcare Company stock has a consensus rating of "Buy" and an average price target of SAR 107.62. The average 1-year stock price forecast is 30.05% higher than the current stock price, while the lowest is SAR 85.00 (+2.72%) and the highest is SAR 133.33 (+61.12%).
Price Target: SAR 107.62 (+30.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dallah Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 1 | 1 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Hold | 3 | 2 | 2 | 3 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 9 |
Financial Forecast
Revenue This Year
4.54B
from 4.07B
Increased by 11.70%
Revenue Next Year
5.01B
from 4.54B
Increased by 10.35%
EPS This Year
4.60
from 4.43
Increased by 3.78%
EPS Next Year
4.65
from 4.60
Increased by 1.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.